Moreover, the findings support our previous inference that via manipulating CRMP2 profiles (including s-CRMP2/f-CRMP2 balance and pCRMP2 level) and thus the cytoskeleton dynamics by environmental glucose may determine proliferation and malignant characteristics of cancer cells. The gene discussed is DPYSL2; the disease is cancer.